INMUNE BIO INC
INMB·45782T105·US·Common Stock·Healthcare - Biotechnology-13D/G
INMB (INMUNE BIO INC) is held by 55 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1.2M), AQR CAPITAL MANAGEMENT LLC ($1.1M), BlackRock, Inc. ($507,930). Net institutional sentiment: Mixed.
55
Holders
(6 Elite)
$6.5M
Total Value
50% (64)
Consensus
32 buying - 32 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 12, 2026 · Insiders Jul 7, 2026 · Activists Aug 14, 2025 · Congress none
InsiderLWLowdell Mark WilliamExercise 7K shJul 2, 2026
InsiderMJMoss David JExercise 9K shJul 2, 2026
InsiderJSJuda ScottExercise 15K shJul 2, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 70
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer